Amrubicin monotherapy in patients with extensive disease small cell lung cancer (ED-SCLC) refractory to first-line platinum-based chemotherapy: final results of a phase 2 trial

被引：0
|
作者：
Ettinger, D. S. [1 ]
Jotte, R. [2 ]
Lorigan, P. [3 ]
Gupta, V. [4 ]
Garbo, L. [5 ]
Spigel, D. [6 ]
Dudek, A. Z. [7 ]
Salgia, R. [8 ]
McNally, R. [9 ]
Renschler, M. [10 ]
机构：
[1] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA
[2] Rocky Mt Canc Ctr US Oncol, Denver, CO USA
[3] Christie Hosp, NHS Fdn Trust, Manchester, Lancs, England
[4] St Joseph Oncol US Oncol, St Joseph, MO USA
[5] New York Oncol Hematol US Oncol, Albany, NY USA
[6] Sarah Cannon Canc Ctr, Nashville, TN USA
[7] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA
[8] Univ Chicago, Chicago, IL 60637 USA
[9] Celgene Corp, Biostat, Summit, NJ USA
[10] Celgene Corp, Clin Dev, Summit, NJ USA
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)71834-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：541 / 541
页数：1
相关论文
共 50 条
  • [41] Pretreatment Inflammatory Indexes are Associated with Response to First-Line Platinum-Based Chemotherapy and Prognosis of Small Cell Lung Cancer Patients
    Inanc, Mevlude
    Bozkurt, Oktay
    Ocak Duran, Ayse
    Ozkan, Metin
    Altinbas, Mustafa
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2019, 29 (02): : 79 - 87
  • [42] PHASE II STUDY OF BELOTECAN AND CISPLATIN AS FIRST-LINE CHEMOTHERAPY FOR EXTENSIVE DISEASE OF SMALL CELL LUNG CANCER: PRELIMINARY RESULTS
    Hong, J.
    Kyung, S. Y.
    Lee, S. P.
    Park, J. W.
    Jung, S. H.
    Sym, S. J.
    Park, J.
    Cho, E.
    Shin, D. B.
    Lee, J. H.
    ANNALS OF ONCOLOGY, 2010, 21 : 149 - 149
  • [43] Phase Ib/II study of the pan-cyclin-dependent kinase (CDK) inhibitor roniciclib (BAY 1000394) in combination with chemotherapy as first-line therapy in subjects with extensive disease small cell lung cancer (ED-SCLC)
    Cho, B. C.
    Dy, G. K.
    Govindan, R.
    Kim, D. W.
    Pennell, N. A.
    Zalcman, G.
    Besse, B.
    Nogai, H.
    Rajagopalan, P.
    Ocker, M.
    Barlesi, F.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S634 - S634
  • [44] Current standards and promising innovations in second-line drug therapy of extensive disease small cell lung cancer (ED-SCLC)
    Pogorzelski, Michael
    Schuler, Martin
    ONKOLOGIE, 2024, 30 (09): : 809 - 816
  • [45] RANDOMIZED PHASE II STUDY OF BELOTECAN OR TOPOTECAN CHEMOTHERAPY AS SECOND-LINE CHEMOTHERAPY AFTER PLATINUM-BASED FIRST-LINE CHEMOTHERAPY FOR SMALL CELL LUNG CANCER
    Yoon, S.
    Lee, D. H.
    Choi, C.
    Lee, J. C.
    Lee, J. S.
    Kim, S.
    ANNALS OF ONCOLOGY, 2014, 25
  • [46] Comparable activity with oral topotecan/cisplatin (TC) and IV etoposide/cisplatin (PE) as treatment for chemotherapy-naive patients (pts) with extensive disease small cell lung cancer (ED-SCLC): Final results of a randomized phase III trial (389)
    Eckardt, JR
    von Pawel, J
    Manikhas, G
    Papai, Z
    Tomova, A
    Tzekova, V
    Crofts, T
    Brannon, S
    Wissel, P
    Ross, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 621S - 621S
  • [47] A phase 2 randomized study of TAS-102 versus topotecan or amrubicin in patients requiring second-line chemotherapy for small cell lung cancer refractory or sensitive to frontline platinum-based chemotherapy
    Scagliotti, Giorgio
    Nishio, Makoto
    Satouchi, Miyako
    Valmadre, Giuseppe
    Niho, Seiji
    Galetta, Domenico
    Cortinovis, Diego
    Benedetti, Fabio
    Yoshihara, Eiji
    Makris, Lukas
    Inoue, Akira
    Kubota, Kaoru
    LUNG CANCER, 2016, 100 : 20 - 23
  • [48] Phase I study of sagopilone (ZK-EPO) in combination with cisplatin in patients with chemotherapy-naive extensive disease small-cell lung cancer (ED-SCLC)
    Gauler, Thomas C.
    Christoph, Daniel
    Gamarra, Fernando
    Fuhr, Heinz-Georg
    Fischer, Juergen R.
    Gonschorek, Christine
    Giurescu, Marius
    Frickhofen, Norbert
    Huber, Rudolf M.
    Schuler, Martin
    Eberhardt, Wilfried E.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S467 - S467
  • [49] Efficacy of Platinum-Based Chemotherapy for Relapsed Small-Cell Lung Cancer after Amrubicin Monotherapy in Elderly Patients and Patients with Poor Performance Status
    Igawa, Satoshi
    Shirasawa, Masayuki
    Fukui, Tomoya
    Nishinarita, Noriko
    Sone, Hideyuki
    Ozawa, Takahiro
    Sugita, Keisuke
    Okuma, Yuriko
    Kurahayashi, Shintaro
    Ono, Taihei
    Sugimoto, Ai
    Mitsufuji, Hisashi
    Kubota, Masaru
    Katagiri, Masato
    Sasaki, Jiichiro
    Naoki, Katsuhiko
    ONCOLOGY, 2018, 94 (04) : 207 - 214
  • [50] Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage- SCLC: Results From the Phase 3 MERU Study
    Johnson, Melissa L.
    Zvirbule, Zanete
    Laktionov, Konstantin
    Helland, Aslaug
    Cho, Byoung Chul
    Gutierrez, Vanesa
    Colinet, Benoit
    Lena, Herve
    Wolf, Martin
    Gottfried, Maya
    Okamoto, Isamu
    van der Leest, Cor
    Rich, Patricia
    Hung, Jen-Yu
    Appenzeller, Christina
    Sun, Zhaowen
    Maag, David
    Luo, Yan
    Nickner, Caroline
    Vajikova, Alena
    Komarnitsky, Philip
    Bar, Jair
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (09) : 1570 - 1581
12345